Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

NCT01019876 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Bone Marrow Failure
Osteopetrosis
Fanconi Anemia
Severe Combined Immunodeficiency

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Busulfan
DRUG: Alemtuzumab
DRUG: Rabbit Anti-thymocyte Globulin
DRUG: Horse Anti-thymocyte Globulin

Sponsor

Columbia University